Search research articles
Contact Us
Filters
Showing results (81-90 of 149) with videos related to
Page
of 15
Sort By:
Biochemical and Biophysical Research Communications
|
December 29, 2017
DANFIN functions as an inhibitor of transcription factor NF-κB and potentiates the antitumor effect of bortezomib in multiple myeloma
Atsushi Uematsu, Kohki Kido, Erika Manabe, et al.
Journal of Bone and Mineral Metabolism
|
February 21, 2009
Osteoinductive capacity and heat stability of recombinant human bone morphogenetic protein-2 produced by Escherichia coli and dimerized by biochemical processing
Koichi Yano, Masatoshi Hoshino, Yoichi Ohta, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association
|
August 20, 2010
New treatment method for developmental dysplasia of the hips after walking age: arthroscopic reduction with limboplasty based on the findings of preoperative imaging
Toshio Kitano, Yuuki Imai, Mitsuaki Morita, et al.
International Orthopaedics
|
June 17, 2009
Repair of experimentally induced large osteochondral defects in rabbit knee with various concentrations of Escherichia coli-derived recombinant human bone morphogenetic protein-2
Yoshio Tokuhara, Shigeyuki Wakitani, Yuuki Imai, et al.
Journal of Bone and Mineral Metabolism
|
March 3, 2009
RNA interference for noggin enhances the biological activity of bone morphogenetic proteins in vivo and in vitro
Kazushi Takayama, Akinobu Suzuki, Tomoya Manaka, et al.
Scientific Reports
|
April 28, 2016
sFRP4-dependent Wnt signal modulation is critical for bone remodeling during postnatal development and age-related bone loss
Ryuma Haraguchi, Riko Kitazawa, Kiyoshi Mori, et al.
Biochemical and Biophysical Research Communications
|
November 6, 2016
Local co-application of zoledronate promotes long-term maintenance of newly formed bone induced by recombinant human bone morphogenetic protein 2
Koichi Ichikawa, Yoichi Ohta, Kenji Mamoto, et al.
Cancer Medicine
|
November 20, 2025
CDH11 Contributes to Bladder Cancer Progression via Regulation of Mitochondrial Energy Metabolism
Osuke Arai, Yuta Yanagihara, Haruna Arai, et al.
Bone
|
February 17, 2019
Zscan10 suppresses osteoclast differentiation by regulating expression of Haptoglobin
Yuta Yanagihara, Kazuki Inoue, Noritaka Saeki, et al.
BMC Musculoskeletal Disorders
|
January 21, 2021
Topical co-administration of zoledronate with recombinant human bone morphogenetic protein-2 can induce and maintain bone formation in the bone marrow environment
Hideki Ueyama, Yoichi Ohta, Yuuki Imai, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 149) with videos related to
Sort By:
Page
of 15
Biochemical and Biophysical Research Communications
|
December 29, 2017
DANFIN functions as an inhibitor of transcription factor NF-κB and potentiates the antitumor effect of bortezomib in multiple myeloma
Atsushi Uematsu, Kohki Kido, Erika Manabe, et al.
Journal of Bone and Mineral Metabolism
|
February 21, 2009
Osteoinductive capacity and heat stability of recombinant human bone morphogenetic protein-2 produced by Escherichia coli and dimerized by biochemical processing
Koichi Yano, Masatoshi Hoshino, Yoichi Ohta, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association
|
August 20, 2010
New treatment method for developmental dysplasia of the hips after walking age: arthroscopic reduction with limboplasty based on the findings of preoperative imaging
Toshio Kitano, Yuuki Imai, Mitsuaki Morita, et al.
International Orthopaedics
|
June 17, 2009
Repair of experimentally induced large osteochondral defects in rabbit knee with various concentrations of Escherichia coli-derived recombinant human bone morphogenetic protein-2
Yoshio Tokuhara, Shigeyuki Wakitani, Yuuki Imai, et al.
Journal of Bone and Mineral Metabolism
|
March 3, 2009
RNA interference for noggin enhances the biological activity of bone morphogenetic proteins in vivo and in vitro
Kazushi Takayama, Akinobu Suzuki, Tomoya Manaka, et al.
Scientific Reports
|
April 28, 2016
sFRP4-dependent Wnt signal modulation is critical for bone remodeling during postnatal development and age-related bone loss
Ryuma Haraguchi, Riko Kitazawa, Kiyoshi Mori, et al.
Biochemical and Biophysical Research Communications
|
November 6, 2016
Local co-application of zoledronate promotes long-term maintenance of newly formed bone induced by recombinant human bone morphogenetic protein 2
Koichi Ichikawa, Yoichi Ohta, Kenji Mamoto, et al.
Cancer Medicine
|
November 20, 2025
CDH11 Contributes to Bladder Cancer Progression via Regulation of Mitochondrial Energy Metabolism
Osuke Arai, Yuta Yanagihara, Haruna Arai, et al.
Bone
|
February 17, 2019
Zscan10 suppresses osteoclast differentiation by regulating expression of Haptoglobin
Yuta Yanagihara, Kazuki Inoue, Noritaka Saeki, et al.
BMC Musculoskeletal Disorders
|
January 21, 2021
Topical co-administration of zoledronate with recombinant human bone morphogenetic protein-2 can induce and maintain bone formation in the bone marrow environment
Hideki Ueyama, Yoichi Ohta, Yuuki Imai, et al.
Page
of 15